Decades ago, healthcare professionals along with the rest of the population were swamped with promotional direct mail. But in recent years, new technology like email, SMS, mobile applications, and AR/VR have diversified the ways in which healthcare marketers can reach physicians.
Change is inevitable, and evolving and growing with it is the only way to move forward. That’s just a fact. Those in our industry who aren’t willing to embrace the constant changes we’re seeing in technology, trends, and now how we market health and wellness brands, are going to be left behind because journal ads, banner ads and TV commercials as exclusive mediums will likely not sufficiently reach a brand’s target audiences any longer.
ZS oncology experts Christina Corridon and Pavan Anne discuss their recent survey of physicians, payers, and pharmacy managers regarding attitudes toward biosimilars
Most health plans are covering at least one of the two biosimilar products currently on the market, according to new research by the strategic advisory company Avalere.
Four in five oncologists have tried Zarxio/Granix, according to a new survey by ZS Associates. Of those, 48 percent prescribe the reference biologic more than the biosimilar, 43 percent prescribe the biosimilar more, and 8 percent have equal prescriptions for the reference biologic and the biosimilar.
At its core, “Customer experience,” or CX, is shorthand for the relationship between a customer and a company, even if that company is removed from the point of sale. The CX relationship should stretch across all touchpoints both physical and virtual and all media in between. Today’s customers expect companies to know and understand them, creating a seamless experience across the entire customer-company relationship.
Just 27 percent of physicians say they find pharma websites to be a credible source of professional information, according to a recent survey by Manhattan Research.
The Fishawack Group of Companies – one of the largest independent medical communications organizations – acquired the Carling Group of Companies, based in San Diego, Calif.
Fingerpaint named a longtime creative duo as the new leaders of the agency’s creative team. Katie Beller and Andy Spitzer are based in the agency’s headquarters in Saratoga Springs, New York.
Keri Hettel was made senior VP, Analytics and Strategy, and Brandon Ashcraft was promoted to senior VP, Operations, at Razorfish Health.
